About Invacare (NYSE:IVC)
Invacare Corporation, together with its subsidiaries, designs, manufactures, distributes, and exports medical equipment for use in home health care, retail, and extended care markets worldwide. The company operates through four segments: North America/Home Medical Equipment, Institutional Products Group, Europe, and the Asia/Pacific. It offers mobility and seating products, such as power wheelchairs under the Invacare TDX brand; custom manual wheelchairs under the Invacare, Invacare Top End, and Küschall brand names; and seating and positioning products. The company also provides lifestyle products, including pressure relieving overlays and mattress replacement systems under the Invacare Softform and microAIR brands; safe resident handling products; residential care and home beds and bed accessories, and manual wheelchairs under the Invacare brand name; and personal care products. In addition, the company offers respiratory therapy products comprising stationary oxygen concentrators under the Perfecto2, Perfecto2 V, and Platinum brands; Invacare HomeFill oxygen systems; and Invacare SOLO2 and XPO2 transportable oxygen concentrators. Further, it sells and distributes healthcare furnishings consisting of long-term care beds, case goods, safe patient handling equipment, and other equipment and accessories for long-term care customers. It sells its products primarily to home medical equipment providers through retail and e-commerce channels, as well as to residential care operators, distributors, and government health service customers through its sales force, independent manufacturers' representatives, and distributors. Invacare Corporation was founded in 1885 and is headquartered in Elyria, Ohio.
Industry, Sector and Symbol
Industry MED PRODS
Sub-IndustryHealth Care Equipment
Trailing P/E Ratio-7.34042553191489
Forward P/E Ratio-15.00
Sales & Book Value
Annual Sales$966.50 million
Price / Sales0.70
Price / CashN/A
Book Value$10.80 per share
Price / Book1.60
Return on Equity-14.95%
Return on Assets-6.31%
Invacare (NYSE:IVC) Frequently Asked Questions
What is Invacare's stock symbol?
Invacare trades on the New York Stock Exchange (NYSE) under the ticker symbol "IVC."
How often does Invacare pay dividends? What is the dividend yield for Invacare?
Invacare declared a quarterly dividend on Thursday, February 22nd. Investors of record on Wednesday, April 4th will be given a dividend of $0.0125 per share on Wednesday, April 18th. This represents a $0.05 annualized dividend and a yield of 0.29%. The ex-dividend date is Tuesday, April 3rd. View Invacare's Dividend History.
How were Invacare's earnings last quarter?
Invacare (NYSE:IVC) issued its quarterly earnings data on Wednesday, February, 7th. The health services provider reported ($0.42) earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of ($0.44) by $0.02. The health services provider earned $250.35 million during the quarter, compared to analyst estimates of $241.07 million. Invacare had a negative net margin of 7.92% and a negative return on equity of 14.95%. The firm's quarterly revenue was up 1.5% compared to the same quarter last year. During the same period in the previous year, the company earned ($0.46) earnings per share. View Invacare's Earnings History.
When will Invacare make its next earnings announcement?
Where is Invacare's stock going? Where will Invacare's stock price be in 2018?
3 equities research analysts have issued 1 year price objectives for Invacare's stock. Their forecasts range from $12.00 to $21.00. On average, they expect Invacare's share price to reach $16.50 in the next twelve months. View Analyst Ratings for Invacare.
Who are some of Invacare's key competitors?
Some companies that are related to Invacare include Varex Imaging (VREX), Accelerate Diagnostics (AXDX), TG Therapeutics (TGTX), Glaukos (GKOS), Natus Medical (BABY), Intersect ENT (XENT), Atrion (ATRI), Orthofix International (OFIX), OraSure Technologies (OSUR), MacroGenics (MGNX), Owens & Minor (OMI), Luminex (LMNX), K2M Group (KTWO), Eagle Pharmaceuticals (EGRX), Cardiovascular Systems (CSII), Cerus (CERS), LeMaitre Vascular (LMAT) and AtriCure (ATRC).
Who are Invacare's key executives?
Invacare's management team includes the folowing people:
- Mr. Matthew E. Monaghan, Chairman, Pres & CEO (Age 50)
- Mr. Anthony C. LaPlaca, Sr. VP, Gen. Counsel & Sec. (Age 60)
- Mr. Dean J. Childers, Sr. VP & GM of North America (Age 51)
- Ms. Kathleen P. Leneghan, Sr. VP, CFO & Principal Accounting Officer (Age 55)
- Ms. Lara L. Mahoney, VP of Investor Relations & Corp. Communications
Has Invacare been receiving favorable news coverage?
Media headlines about IVC stock have been trending somewhat positive recently, according to Accern Sentiment Analysis. Accern rates the sentiment of media coverage by analyzing more than 20 million blog and news sources. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Invacare earned a daily sentiment score of 0.24 on Accern's scale. They also assigned news headlines about the health services provider an impact score of 46.90 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the stock's share price in the near term.
Who are Invacare's major shareholders?
Invacare's stock is owned by many different of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (11.39%), Barrow Hanley Mewhinney & Strauss LLC (6.02%), Royce & Associates LP (4.02%), Northpointe Capital LLC (2.30%), Wells Fargo & Company MN (1.23%) and AlphaOne Investment Services LLC (1.17%). Company insiders that own Invacare stock include Anthony Laplaca, Baiju R Shah, C Martin Harris, Clifford D Nastas, Dale C Laporte, Dean J Childers and Matthew E Monaghan. View Institutional Ownership Trends for Invacare.
Which major investors are selling Invacare stock?
IVC stock was sold by a variety of institutional investors in the last quarter, including Brandes Investment Partners LP, BlackRock Inc., Northpointe Capital LLC, Adirondack Research & Management Inc., Guggenheim Capital LLC, Heartland Advisors Inc., Alambic Investment Management L.P. and Tocqueville Asset Management L.P.. Company insiders that have sold Invacare company stock in the last year include C Martin Harris, Dale C Laporte and Dean J Childers. View Insider Buying and Selling for Invacare.
Which major investors are buying Invacare stock?
IVC stock was purchased by a variety of institutional investors in the last quarter, including WINTON GROUP Ltd, Millennium Management LLC, Royce & Associates LP, AXA, EAM Investors LLC, Eversept Partners LLC, Renaissance Technologies LLC and Arizona State Retirement System. Company insiders that have bought Invacare stock in the last two years include Anthony Laplaca, Baiju R Shah, Clifford D Nastas, Dean J Childers and Matthew E Monaghan. View Insider Buying and Selling for Invacare.
How do I buy shares of Invacare?
Shares of IVC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Invacare's stock price today?
One share of IVC stock can currently be purchased for approximately $17.25.
How big of a company is Invacare?
Invacare has a market capitalization of $703.41 million and generates $966.50 million in revenue each year. The health services provider earns $-76,540,000.00 in net income (profit) each year or ($2.35) on an earnings per share basis. Invacare employs 4,200 workers across the globe.
How can I contact Invacare?
Invacare's mailing address is ONE INVACARE WAY, ELYRIA OH, 44036. The health services provider can be reached via phone at 440-329-6000 or via email at [email protected]
MarketBeat Community Rating for Invacare (IVC)MarketBeat's community ratings are surveys of what our community members think about Invacare and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Invacare (NYSE:IVC) Earnings History and Estimates Chart
Invacare (NYSE IVC) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|2/7/2018||Q4 2017||($0.44)||($0.42)||$241.07 million||$250.35 million||View||N/A|
|11/7/2017||Q3 2017||($0.43)||($0.41)||$239.88 million||$250.91 million||View||N/A|
|8/7/2017||Q2 2017||($0.42)||($0.63)||$243.03 million||$233.50 million||View||Listen|
|5/8/2017||Q1 17||($0.53)||($0.47)||$226.71 million||$231.70 million||View||Listen|
|2/9/2017||Q416||($0.30)||($0.46)||$262.53 million||$246.70 million||View||Listen|
|10/31/2016||Q316||($0.20)||($0.37)||$271.47 million||$268.15 million||View||Listen|
|7/28/2016||Q216||($0.24)||($0.33)||$270.10 million||$275.00 million||View||Listen|
|4/28/2016||Q116||($0.22)||($0.25)||$272.17 million||$257.60 million||View||N/A|
|2/11/2016||Q415||($0.16)||($0.06)||$284.83 million||$283.26 million||View||Listen|
|10/22/2015||Q315||($0.22)||($0.13)||$286.63 million||$283.80 million||View||Listen|
|7/23/2015||Q215||($0.20)||($0.23)||$296.07 million||$286.30 million||View||Listen|
|4/23/2015||Q115||($0.29)||($0.21)||$275.85 million||$289.00 million||View||N/A|
|2/5/2015||Q414||($0.23)||($0.12)||$310.40 million||$318.20 million||View||N/A|
|10/23/2014||Q314||($0.26)||($0.56)||$331.60 million||$320.50 million||View||N/A|
|7/24/2014||Q214||($0.28)||($0.36)||$327.85 million||$331.31 million||View||N/A|
|4/24/2014||Q114||($0.22)||($0.49)||$326.90 million||$309.10 million||View||N/A|
|2/6/2014||Q413||($0.18)||$0.19||$336.20 million||$334.99 million||View||N/A|
|10/24/2013||Q313||($0.26)||($0.18)||$333.10 million||$341.20 million||View||N/A|
|7/25/2013||Q2 2013||($0.20)||($0.27)||$320.00 million||$351.80 million||View||N/A|
|4/25/2013||Q1 2013||($0.09)||($0.36)||$310.00 million||$337.60 million||View||N/A|
|2/8/2013||Q4 2012||$0.25||$0.21||$422.70 million||$360.42 million||View||N/A|
Invacare (NYSE:IVC) Earnings Estimates
2018 EPS Consensus Estimate: ($1.15)
(Earnings estimates data provided by Zacks Investment Research)
|Quarter||Number of Estimates||Low Estimate||High Estimate||Average Estimate|
Invacare (NYSE:IVC) Dividend Information
|Dividend Growth:||0.00% (3 Year Average)|
|Payout Ratio:||-2.13% (Trailing 12 Months of Earnings) |
-4.35% (Based on This Year's Estimates)
-20.83% (Based on Next Year's Estimates)
Invacare (NYSE:IVC) Dividend History by Quarter
(Data available from 1/1/2013 forward)
|Announced||Period||Amount||Yield||Ex-Dividend Date||Record Date||Payable Date|
Invacare (NYSE IVC) Insider Trading and Institutional Ownership History
Insider Ownership Percentage: 2.60%
Invacare (NYSE IVC) Insider Trades by Quarter
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Shares Held After Transaction||Details|
|2/15/2018||C Martin Harris||Director||Sell||3,443||$18.15||$62,490.45|| |
|9/13/2017||Dean J Childers||SVP||Sell||6,249||$15.15||$94,672.35||44,875|| |
|5/16/2017||Dale C. Laporte||Director||Sell||2,737||$14.95||$40,918.15|| |
|11/16/2016||Dale C. Laporte||Director||Sell||375||$11.90||$4,462.50|| |
|11/2/2016||Baiju R. Shah||Director||Buy||1,000||$9.04||$9,040.00|| |
|11/2/2016||Matthew E Monaghan||Chairman||Buy||11,000||$9.00||$99,000.00||145,773|| |
|8/4/2016||C Martin Harris||Director||Sell||475||$11.49||$5,457.75|| |
|5/17/2016||Dale C Laporte||Director||Sell||375||$10.33||$3,873.75||35,697|| |
|5/16/2016||Dean J Childers||SVP||Buy||10,000||$10.40||$104,000.00||35,672|| |
|5/6/2016||Clifford D Nastas||Director||Buy||5,000||$11.01||$55,050.00||14,932|| |
|5/3/2016||Matthew E Monaghan||CEO||Buy||4,500||$11.39||$51,255.00||140,455|| |
|5/2/2016||Anthony Laplaca||VP||Buy||1,000||$11.23||$11,230.00||40,074|| |
|5/2/2016||Baiju R Shah||Director||Buy||2,000||$11.27||$22,540.00||30,627|| |
|2/29/2016||Anthony Laplaca||VP||Buy||1,000||$12.38||$12,380.00||27,684|| |
|2/29/2016||Matthew E Monaghan||CEO||Buy||8,000||$12.31||$98,480.00||82,327|| |
|2/29/2016||Robert K Gudbranson||CFO||Buy||4,200||$12.01||$50,442.00||101,821|| |
|12/10/2015||Michael F. Delaney||Director||Sell||1,000||$19.05||$19,050.00||4,254|| |
|12/8/2014||C Martin Harris||Director||Sell||1,125||$16.22||$18,247.50|| |
|12/9/2013||C Martin Harris||Director||Sell||1,775||$22.15||$39,316.25||16,806|| |
|5/6/2013||Joseph B Richey II||SVP||Buy||1,000||$13.74||$13,740.00|| |
|5/1/2013||Gerald B Blouch||CEO||Buy||1,000||$13.59||$13,590.00|| |
|4/30/2013||Aaron Malachi Mixon III||Chairman||Buy||4,300||$13.22||$56,846.00|| |
|4/30/2013||Louis F J Slangen||SVP||Buy||1,000||$13.05||$13,050.00|| |
|4/29/2013||Aaron Malachi Mixon III||Chairman||Buy||45,700||$12.53||$572,621.00|| |
|4/29/2013||Dale C Laporte||Director||Buy||1,000||$12.24||$12,240.00|| |
Invacare (NYSE IVC) News Headlines
|KeyCorp Reiterates Buy Rating for Invacare (IVC)|
www.americanbankingnews.com - March 15 at 4:20 PM
|Analyzing Invacare (IVC) and Orthofix International (OFIX)|
www.americanbankingnews.com - March 11 at 1:22 AM
|Invacare Co. (IVC) Given Average Rating of "Hold" by Brokerages|
www.americanbankingnews.com - March 10 at 4:14 AM
|Invacare (IVC) Upgraded at ValuEngine|
www.americanbankingnews.com - March 4 at 3:54 PM
|127,773 Shares in Invacare Co. (IVC) Acquired by EAM Investors LLC|
www.americanbankingnews.com - March 1 at 12:13 PM
|Brandes Investment Partners LP Decreases Holdings in Invacare Co. (IVC)|
www.americanbankingnews.com - February 28 at 5:18 AM
|Adirondack Research & Management Inc. Sells 244,678 Shares of Invacare Co. (IVC)|
www.americanbankingnews.com - February 26 at 5:10 AM
|AlphaOne Investment Services LLC Acquires 3,532 Shares of Invacare Co. (IVC)|
www.americanbankingnews.com - February 26 at 5:08 AM
|Invacare Co. (IVC) Stake Increased by Victory Capital Management Inc.|
www.americanbankingnews.com - February 24 at 4:54 AM
|Invacare Appoints Kathleen Leneghan Chief Financial Officer|
finance.yahoo.com - February 23 at 5:15 PM
|Invacare makes Lenegthan permanent CFO; says Merriman will exit board|
seekingalpha.com - February 22 at 7:40 PM
|Invacare declares $0.0125 dividend|
seekingalpha.com - February 22 at 5:05 PM
|Invacare Co. (IVC) Plans Quarterly Dividend of $0.01|
www.americanbankingnews.com - February 22 at 1:26 PM
|Invacare Co. (IVC) Director C Martin Harris Sells 3,443 Shares|
www.americanbankingnews.com - February 20 at 7:32 PM
|BRIEF-Invacare Corp Transfers Küschall Wheelchair Production From Switzerland To France|
www.reuters.com - February 13 at 4:12 PM
|Invacare Corporation Transfers Küschall Wheelchair Production from Switzerland to France|
finance.yahoo.com - February 13 at 9:30 AM
|Invacare Co. (IVC) Receives Average Recommendation of "Hold" from Analysts|
www.americanbankingnews.com - February 13 at 3:48 AM
|Invacare Co. Expected to Post Q1 2018 Earnings of ($0.48) Per Share (IVC)|
www.americanbankingnews.com - February 12 at 2:20 AM
|KeyCorp Increases Invacare (IVC) Price Target to $21.00|
www.americanbankingnews.com - February 10 at 6:22 PM
|BRIEF-Invacare Corp Reports Q4 Loss Per Share $0.54|
www.reuters.com - February 9 at 9:26 AM
|New Research Coverage Highlights Carter's, Invacare, Hortonworks, BGC Partners, Hyatt Hotels, and Aldeyra Therapeutics — Consolidated Revenues, Company Growth, and Expectations for 2018|
finance.yahoo.com - February 9 at 9:26 AM
|Invacare (IVC) Announces Quarterly Earnings Results, Beats Estimates By $0.02 EPS|
www.americanbankingnews.com - February 8 at 2:56 PM
|Is Invacare Corporation (NYSE:IVC) Worth $17.45 Based On Its Intrinsic Value?|
finance.yahoo.com - February 7 at 9:29 AM
|Invacare (IVC) to Release Earnings on Wednesday|
www.americanbankingnews.com - January 31 at 2:28 AM
|Critical Review: Palomar Medical Technologies (PMTI) and Invacare (IVC)|
www.americanbankingnews.com - January 30 at 9:23 AM
|Contrasting Lombard Medical (EVARF) & Invacare (IVC)|
www.americanbankingnews.com - January 24 at 9:34 AM
|FY2017 EPS Estimates for Invacare Co. (IVC) Reduced by Analyst|
www.americanbankingnews.com - January 22 at 2:18 AM
|Invacare Co. (IVC) Receives Average Rating of "Hold" from Brokerages|
www.americanbankingnews.com - January 19 at 4:34 AM
|Invacare (IVC) Upgraded by ValuEngine to "Hold"|
www.americanbankingnews.com - January 1 at 8:14 PM
|Invacare Corporation (IVC) Given Average Recommendation of "Hold" by Brokerages|
www.americanbankingnews.com - December 25 at 4:20 AM
|Invacare (IVC) Stock Rating Reaffirmed by KeyCorp|
www.americanbankingnews.com - December 21 at 8:40 PM
|Omnicell, Inc. (OMCL)|
finance.yahoo.com - December 19 at 3:39 PM
|ETFs with exposure to Invacare Corp. : December 12, 2017|
finance.yahoo.com - December 12 at 3:42 PM
|Comparing K2M Group (KTWO) and Invacare (IVC)|
www.americanbankingnews.com - December 6 at 1:46 AM
|Invacare Corporation (IVC) Receives Consensus Rating of "Hold" from Analysts|
www.americanbankingnews.com - November 30 at 4:08 AM
|Invacare Corporation (IVC) Downgraded by Zacks Investment Research|
www.americanbankingnews.com - November 26 at 12:08 AM
|Invacare Corp. :IVC-US: Earnings Analysis: Q3, 2017 By the Numbers : November 21, 2017|
finance.yahoo.com - November 21 at 8:17 PM
|Invacare Corporation Announces Quarterly Dividend of $0.01 (IVC)|
www.americanbankingnews.com - November 16 at 11:30 AM
|Invacare Corporation to Post FY2017 Earnings of ($1.93) Per Share, KeyCorp Forecasts (IVC)|
www.americanbankingnews.com - November 13 at 3:00 AM
|Invacare Corp. breached its 50 day moving average in a Bullish Manner : IVC-US : November 9, 2017|
finance.yahoo.com - November 12 at 12:02 AM
|Invacare Corporation (IVC) Earns "Buy" Rating from KeyCorp|
www.americanbankingnews.com - November 11 at 12:20 PM
|Invacare Reports Results for Third Quarter 2017|
finance.yahoo.com - November 8 at 10:42 AM
|Invacare reports 3Q loss|
finance.yahoo.com - November 8 at 10:42 AM
|Invacare Corporation to Host Earnings Call|
finance.yahoo.com - November 8 at 10:42 AM
|Invacare Corporation (IVC) Issues Quarterly Earnings Results, Beats Expectations By $0.01 EPS|
www.americanbankingnews.com - November 7 at 5:27 PM
|Invacare Announces Departure of Chief Financial Officer|
finance.yahoo.com - November 3 at 10:57 AM
|Invacare Corporation (IVC) to Release Earnings on Tuesday|
www.americanbankingnews.com - October 31 at 1:34 PM
|Q3 2017 EPS Estimates for Invacare Corporation Reduced by KeyCorp (IVC)|
www.americanbankingnews.com - October 30 at 1:24 AM
|Invacare Expands Healthcare Informatics Platform to Oxygen Technology|
finance.yahoo.com - October 24 at 5:22 PM
|Invacare Corporation to Host Conference Call and Webcast to Discuss Third Quarter 2017 Financial Results|
finance.yahoo.com - October 23 at 7:45 PM
Invacare (NYSE:IVC) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Invacare (NYSE:IVC) Income Statement, Balance Sheet and Cash Flow Statement
Invacare (NYSE IVC) Stock Chart for Saturday, March, 24, 2018